We publish our audit record because accuracy claims should be checkable. Every entry on this site runs through an automated fact-audit pipeline (accuracy audit → source-grounded repair → visual QA); this page is generated from that pipeline's own report, not written by hand.
Last full accuracy audit: 2026-09-07 · 33 entries checked · 16 flagged · 27 issues confirmed · 16 corrected · 11 still open
Rare disease — The entry states 'In 2019, the Monarch Initiative released a rare disease subset of the Mondo ontology... revealing over 10,500 rare diseases' but the STATS section says 'estimated number of rare diseases global=approximately 10,000', which contradicts the 10,
AA amyloidosis — The 'DID YOU KNOW' section states 'AA amyloidosis commonly affects the kidneys, liver, and stomach,' but the spleen is a commonly affected organ and the stomach is not typically cited as a primary site.
Abetalipoproteinemia — High-dose vitamin E therapy does not restore or produce lipoproteins; it primarily prevents or slows neurological and retinal damage but does not correct the underlying lipoprotein deficiency.
Absent pulmonary valve syndrome — The first case of absent pulmonary valve syndrome was not reported by Crampton in 1830; the earliest known description is often attributed to Chevers in 1846 or later.
Absent pulmonary valve syndrome — The statement that about 25% of cases have a 22q11 microdeletion is incorrect; the actual rate is significantly higher, often reported as 30-50% or more.
Achromatopsia — The entry states 'PDEH' as a genetic cause, but the correct gene is 'PDE6H'
Achromatopsia — The claim that 'The fundus of the eye appears completely normal' is misleading because in some cases subtle abnormalities like foveal hypoplasia or atrophy can be present
Acute disseminated encephalomyelitis — The claim that 'the only vaccine proven related to ADEM is the Semple form of the rabies vaccine' is factually incorrect; multiple vaccines have been associated with ADEM in medical literature.
Adenosine deaminase deficiency — The LORE section incorrectly claims 'The ADA gene was used as a marker for bone marrow transplants.' The correct fact is that ADA deficiency was identified when Giblett found a lack of ADA enzyme activity in a patient being evaluated for a bone marrow transpla
Adenosine deaminase deficiency — The LORE section says 'After discovering a second case of ADA deficiency in an immunocompromised patient, ADA deficiency was recognized as the first immunodeficiency disorder.' This is inaccurate; ADA deficiency was the first identified cause of SCID, but the
Adenosine monophosphate deaminase deficiency type 1 — The description of the rarer genetic cause as 'Homozygous G;G replaced by A;A' is not a recognized standard description for a known rarer cause of AMPD1 deficiency.
All content is fetchable as JSON at /data/content/ · llms.txt · sitemap
Spotted an error? Suggest an edit — reader reports go straight into the audit queue.